Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Endometrial histology in severely obese bariatric surgery candidates: an exploratory analysis.

Kaiyrlykyzy A, Freese KE, Elishaev E, Bovbjerg DH, Ramanathan R, G Hamad G, McCloskey C, D Althouse A, Huang M, Edwards RP, Linkov F.

Surg Obes Relat Dis. 2014 Dec 19. pii: S1550-7289(14)00492-4. doi: 10.1016/j.soard.2014.12.010. [Epub ahead of print]

PMID:
25820079
2.

Bariatric surgery-induced weight loss changes immune markers in the endometrium of morbidly obese women.

Linkov F, Elishaev E, Gloyeske N, Edwards R, Althouse AD, Geller MA, Svendsen C, Argenta PA.

Surg Obes Relat Dis. 2014 Sep-Oct;10(5):921-6. doi: 10.1016/j.soard.2014.03.023. Epub 2014 Apr 19.

PMID:
25439003
3.

Immunohistochemical Profile of Breast Cancer With Respect to Estrogen Receptor and HER2 Status.

Gloyeske NC, Woodard AH, Elishaev E, Yu J, Clark BZ, Dabbs DJ, Bhargava R.

Appl Immunohistochem Mol Morphol. 2015 Mar;23(3):202-8. doi: 10.1097/PAI.0000000000000076.

PMID:
25356941
4.

Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer.

Suryawanshi S, Huang X, Elishaev E, Budiu RA, Zhang L, Kim S, Donnellan N, Mantia-Smaldone G, Ma T, Tseng G, Lee T, Mansuria S, Edwards RP, Vlad AM.

Clin Cancer Res. 2014 Dec 1;20(23):6163-74. doi: 10.1158/1078-0432.CCR-14-1338. Epub 2014 Oct 7.

PMID:
25294912
5.

MUC1 positive, Kras and Pten driven mouse gynecologic tumors replicate human tumors and vary in survival and nuclear grade based on anatomical location.

Tirodkar TS, Budiu RA, Elishaev E, Zhang L, Mony JT, Brozick J, Edwards RP, Vlad AM.

PLoS One. 2014 Jul 31;9(7):e102409. doi: 10.1371/journal.pone.0102409. eCollection 2014.

6.

Topical application of trichloroacetic acid is efficacious for the treatment of internal anal high-grade squamous intraepithelial lesions in HIV-positive men.

Cranston RD, Baker JR, Liu Y, Wang L, Elishaev E, Ho KS.

Sex Transm Dis. 2014 Jul;41(7):420-6. doi: 10.1097/OLQ.0000000000000145.

PMID:
24922100
7.

Hormone receptor expression patterns in the endometrium of asymptomatic morbidly obese women before and after bariatric surgery.

Argenta P, Svendsen C, Elishaev E, Gloyeske N, Geller MA, Edwards RP, Linkov F.

Gynecol Oncol. 2014 Apr;133(1):78-82. doi: 10.1016/j.ygyno.2013.12.005.

PMID:
24680595
8.

Integrated genomic characterization of endometrial carcinoma.

Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA.

Nature. 2013 May 2;497(7447):67-73. doi: 10.1038/nature12113. Erratum in: Nature. 2013 Aug 8;500(7461):242.

9.

Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer.

Suryawanshi S, Vlad AM, Lin HM, Mantia-Smaldone G, Laskey R, Lee M, Lin Y, Donnellan N, Klein-Patel M, Lee T, Mansuria S, Elishaev E, Budiu R, Edwards RP, Huang X.

Clin Cancer Res. 2013 Mar 1;19(5):1213-24. doi: 10.1158/1078-0432.CCR-12-2726. Epub 2013 Jan 29.

10.

Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors.

Jones MW, Onisko A, Dabbs DJ, Elishaev E, Chiosea S, Bhargava R.

Int J Gynecol Cancer. 2013 Feb;23(2):380-4. doi: 10.1097/IGC.0b013e31825cc8ee.

PMID:
23318908
11.

Immunobiology of human mucin 1 in a preclinical ovarian tumor model.

Budiu RA, Elishaev E, Brozick J, Lee M, Edwards RP, Kalinski P, Vlad AM.

Oncogene. 2013 Aug 8;32(32):3664-75. doi: 10.1038/onc.2012.397. Epub 2012 Sep 10.

12.

17β Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma.

Szajnik M, Szczepanski MJ, Elishaev E, Visus C, Lenzner D, Zabel M, Glura M, DeLeo AB, Whiteside TL.

Gynecol Oncol. 2012 Dec;127(3):587-94. doi: 10.1016/j.ygyno.2012.08.010. Epub 2012 Aug 17.

13.

Uterine adenosarcomas: diagnostic use of the proliferation marker Ki-67 as an adjunct to morphologic diagnosis.

Aggarwal N, Bhargava R, Elishaev E.

Int J Gynecol Pathol. 2012 Sep;31(5):447-52. doi: 10.1097/PGP.0b013e318249285b.

PMID:
22833085
14.

NY-BR-1 and PAX8 immunoreactivity in breast, gynecologic tract, and other CK7+ carcinomas: potential use for determining site of origin.

Woodard AH, Yu J, Dabbs DJ, Beriwal S, Florea AV, Elishaev E, Davison JM, Krasinskas AM, Bhargava R.

Am J Clin Pathol. 2011 Sep;136(3):428-35. doi: 10.1309/AJCPUFNMEZ3MK1BK.

15.

Noninvasive assessment of cell proliferation in ovarian cancer using [18F] 3'deoxy-3-fluorothymidine positron emission tomography/computed tomography imaging.

Richard SD, Bencherif B, Edwards RP, Elishaev E, Krivak TC, Mountz JM, DeLoia JA.

Nucl Med Biol. 2011 May;38(4):485-91. doi: 10.1016/j.nucmedbio.2010.12.003. Epub 2011 Mar 3.

PMID:
21531285
16.

Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer.

Budiu RA, Mantia-Smaldone G, Elishaev E, Chu T, Thaller J, McCabe K, Lenzner D, Edwards RP, Vlad AM.

Cancer Immunol Immunother. 2011 Jul;60(7):975-84. doi: 10.1007/s00262-011-1010-x. Epub 2011 Apr 2.

PMID:
21461842
17.

TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer.

Szajnik M, Szczepanski MJ, Czystowska M, Elishaev E, Mandapathil M, Nowak-Markwitz E, Spaczynski M, Whiteside TL.

Oncogene. 2009 Dec 10;28(49):4353-63. doi: 10.1038/onc.2009.289. Epub .

18.

Sentinel lymph node biopsy in early-stage cervical cancer: utility of intraoperative versus postoperative assessment.

Fader AN, Edwards RP, Cost M, Kanbour-Shakir A, Kelley JL, Schwartz B, Sukumvanich P, Comerci J, Sumkin J, Elishaev E, Rohan LC.

Gynecol Oncol. 2008 Oct;111(1):13-7. doi: 10.1016/j.ygyno.2008.06.009. Epub 2008 Aug 5.

PMID:
18684499
19.

Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary.

Guirguis A, Elishaev E, Oh SH, Tseng GC, Zorn K, DeLoia JA.

Gynecol Oncol. 2008 Feb;108(2):370-6.

PMID:
18083218
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk